AI-backed imaging and care coordination company Viz.ai received FDA 510(k) clearance for an algorithm that could help determine the severity of a pulmonary embolism. The startup received the agency's ...
Overreliance on D-dimer testing and similarity to other conditions may mean pulmonary embolism or venous thromboembolism is ...
TEL AVIV-YAFO, Israel — A hospital in Israel is predicting patients’ risk of suffering pulmonary embolism (PE) — a potentially life-threatening lung blockage and the third most common cause of death ...
The past couple of days have seen a handful of artificial intelligence algorithms for radiology imaging analysis receive 510(k) clearances from the FDA. Two of these, from Quantib and Ezra, are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback